StonvexLoading…
StonvexStonvexStonvexCore line items from BMBL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $965.66M | $1.07B | $1.05B | $903.50M |
Operating Income | $-805.78M | $-700.47M | $53.37M | $-102.84M |
Net Income | $-693.14M | $-557.01M | $-4.21M | $-79.75M |
EPS (Diluted) | $-5.95 | $-4.61 | $-0.03 | $-0.62 |
Total Assets | $1.43B | $2.52B | $3.63B | $3.69B |
Total Liabilities | $743.97M | $1.18B | $1.29B | $1.24B |
Cash & Equivalents | $175.76M | $204.32M | $355.64M | $402.56M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 110.13M | 120.82M | 134.94M | 129.42M |